ArticleBlood cancer journal2022
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients.
Abstract readLetter
In one paragraph
Article in Blood cancer journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Optical genome mapping detects cryptic high-risk and targetable abnormalities in adult AML.British journal of haematology · 2026Article
- Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AML.NPJ precision oncology · 2026Article
- TLX1 translocation variants and enhancer hijacking influence clinical outcome in T-cell acute lymphoblastic leukemia.HemaSphere · 2025Article
- Pilot evaluation of optical genome mapping in chronic lymphocytic leukemia: complementing FISH analysis.BMC cancer · 2025Article
- Rare case of PLAG1::RUNX1 fusion mimicking classical t(8;21): the value of optical genome mapping in acute myeloid leukemia.Molecular cytogenetics · 2025Article
- Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL).Leukemia · 2025Article
- Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes.HemaSphere · 2025Article
- Article
- Unveiling the Complexity ofCancers · 2024Article
- Fusion Genes in Myeloid Malignancies.Cancers · 2024Review
- Genomic structural variants analysis in leukemia by a novel cytogenetic technique: Optical genome mapping.Cancer science · 2024Review
- Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease.British journal of haematology · 2024Review
- Article
- Genomic technologies for detecting structural variations in hematologic malignancies.Blood research · 2024Review
- Analytic Validation of Optical Genome Mapping in Hematological Malignancies.Biomedicines · 2023Article
- Article
- Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.Cancers · 2023Article
- NovelCancers · 2023Article
- Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.Diagnostics (Basel, Switzerland) · 2023Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Estelle Balducci *Laboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France. estelle.balducci@aphp.fr.ORCID 0000-0001-6792-1291
Sophie Kaltenbach *Laboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Patrick VillareseLaboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Eugénie DuroyonLaboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Loria ZalmaiLaboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Chloé FriedrichLaboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Felipe SuarezHematology Department, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Ambroise MarcaisHematology Department, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Didier BouscaryDepartment of Clinical Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Justine DecroocqDepartment of Clinical Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Rudy BirsenDepartment of Clinical Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Michaëla FontenayLaboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Marie TempléLaboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Chantal BrouzesLaboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Aurore TouzartLaboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Thomas SteimléLaboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Agata CieslakLaboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.ORCID 0000-0003-1015-9448
Ludovic LhermitteLaboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.ORCID 0000-0003-2498-0376
Carole AlmireLaboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Nicolas ChapuisLaboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0000-0003-0601-3948
Olivier HermineHematology Department, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Vahid AsnafiLaboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Olivier Kosmider *Laboratory of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0000-0002-6021-4057
Lucile Couronné *Laboratory of Onco-Hematology, Hôpital Necker Enfants-Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesAdultChromosome MappingCytogenetic AnalysisHumansPrognosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.